• Explore /
  • Poster
  • / Efficacy of nivolumab and ipilimumab in patients with hepatocellular carcinoma with prior immune-checkpoint inhibitor treatment.

Efficacy of nivolumab and ipilimumab in patients with hepatocellular carcinoma with prior immune-checkpoint inhibitor treatment.

Abstract Poster

Authors

null

Jaekyung Cheon

Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea;

Jaekyung Cheon , Beodeul Kang , Sang-Hoon Jung , Chan Kim , Hongjae Chon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 554)

DOI

10.1200/JCO.2023.41.4_suppl.554

Abstract #

554

Poster Bd #

D6

Abstract Disclosures

Similar Posters

First Author: Takeshi Terashima

First Author: Keito Suzuki

First Author: Patrick Walsh McGarrah

First Author: Lorenzo Pilla